Sponsored Links
| Clinical Trial Confirms Benefit Of Targeted Lung Cancer Therapy |
 |
 |
 |
| Medical News - Lung Cancer | |||
|
A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology (ASCO)... Read more: Lung Cancer News From Medical News Today
|